Description
Recombinant monoclonal antibody to CD10. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma NL-1. This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.
Target
CD10
Target Alias Names
Neprilysin, Cluster of Differentiation 10, Membrane metallo-endopeptidase, MME, Neutral endopeptidase 24.11, Neutral endopeptidase, NEP, Common acute lymphocytic leukaemia antigen, CALLA, Skin fibroblast elastase, SFE, CMT2T, SCA43, Atriopeptidase, Enkephalinase
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression